Citation Impact
Citing Papers
2017 Standout
Long-term treatment of epilepsy with everolimus in tuberous sclerosis
2016
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
2008 StandoutScience
Hedgehog signalling in cancer formation and maintenance
2003 Standout
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
2011
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
2010 Standout
Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome
2014
The 2004 World Health Organization classification of lung tumors
2005 Standout
Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c
2016 StandoutNobel
Growth Hormone Deficiency in Patients With Idiopathic Adrenocorticotropin Deficiency Resolves During Glucocorticoid Replacement
1989
Immunosuppressants in cancer prevention and therapy
2013
Rapamycin: One Drug, Many Effects
2014 Standout
Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases
2003
The genetic landscape of the epileptic encephalopathies of infancy and childhood
2015
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
2012
Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities
2012
Molecular pathogenesis of lung cancer
1999
TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins
2016 StandoutNobel
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Biological roles of glycans
2016 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
2001
From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis
2009
The Neurology of mTOR
2014
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005 Standout
mTOR Signaling in Epilepsy: Insights from Malformations of Cortical Development
2015
Altered Neuronal and Circuit Excitability in Fragile X Syndrome
2015
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas
2000
AKT/PKB Signaling: Navigating the Network
2017 Standout
The PI3K Pathway in Human Disease
2017 Standout
Drugs for preventing lung cancer in healthy people
2003
Protein Sequence Editing of SKN-1A/Nrf1 by Peptide:N-Glycanase Controls Proteasome Gene Expression
2019 StandoutNobel
Glycoproteomics
2022 StandoutNobel
Selenium in the Environment, Metabolism and Involvement in Body Functions
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Drugs for preventing lung cancer in healthy people
2020
Drugs for preventing lung cancer in healthy people
2012
Combination therapy in combating cancer
2017 Standout
Molecular Pathogenesis of Lung Cancer
2002
Congenital Disorders of Glycosylation from a Neurological Perspective
2021
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Neurological Aspects of Human Glycosylation Disorders
2015
Retinoic Acid Receptor-Beta as a Prognostic Indicator in Stage I Non–Small-Cell Lung Cancer
2000
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Philippe Major being referenced
The genetic landscape of infantile spasms
2014
Self-injurious behavior and tuberous sclerosis complex: Frequency and possible associations in a population of 257 patients
2008
Are cortical tubers epileptogenic? Evidence from electrocorticography
2008
The natural history of epilepsy in tuberous sclerosis complex
2009
Alterations of visual and auditory evoked potentials in fragile X syndrome
2014
Placebo-Controlled Trial of 13-cis-Retinoic Acid Activity on Retinoic Acid Receptor-Beta Expression in a Population at High Risk: Implications for Chemoprevention of Lung Cancer
1999
Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex
2011
Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex
2011
Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex
2010
Selective Hypopituitarism with Severe Hyponatremia and Secondary Hyporeninism*
1978
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly
2013